Figure 4 | Scientific Reports

Figure 4

From: A metabolomics study of Qiliqiangxin in a rat model of heart failure: a reverse pharmacology approach

Figure 4The alternative text for this image may have been generated using AI.

Pathway analysis of metabolites that are increased or decreased in rats with heart failure, and the effect of treatment with QL or benazepril. AA: arachidonic acid; Be: benazepril; COX: cyclooxygenase; CYP450: cytochrome P450; DHA: docosahexaenoic acid; EPA: eicosapentaenoic acid; FFA: free fatty acid; HF: heart failure; LA: linoleic acid; LOX: lipoxygenase; RNS: reactive nitrogen species; TCA: tricarboxylic acid.

Back to article page